Literature DB >> 8611836

A rational approach to the management of hepatitis C infection.

G M Dusheiko1, S Khakoo, P Soni, L Grellier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8611836      PMCID： PMC2350276          DOI： 10.1136/bmj.312.7027.357

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  38 in total

1.  Hepatitis C virus transmitted by human bite.

Authors:  G M Dusheiko; M Smith; P J Scheuer
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

Review 2.  Side effects of alpha interferon.

Authors:  P F Renault; J H Hoofnagle
Journal:  Semin Liver Dis       Date:  1989-11       Impact factor: 6.115

Review 3.  Ribavirin: a clinical overview.

Authors:  H Fernandez; G Banks; R Smith
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

4.  Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection.

Authors:  A S Lok; C L Lai; E K Leung
Journal:  Hepatology       Date:  1990-12       Impact factor: 17.425

5.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

7.  Vertical transmission of hepatitis C virus.

Authors:  M M Thaler; C K Park; D V Landers; D W Wara; M Houghton; G Veereman-Wauters; R L Sweet; J H Han
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

8.  Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.

Authors:  M Lenzi; P J Johnson; I G McFarlane; G Ballardini; H M Smith; B M McFarlane; C Bridger; D Vergani; F B Bianchi; R Williams
Journal:  Lancet       Date:  1991-08-03       Impact factor: 79.321

9.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

10.  Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.

Authors:  M Shindo; K Arai; Y Sokawa; T Okuno
Journal:  Ann Intern Med       Date:  1995-04-15       Impact factor: 25.391
View more
  6 in total

Review 1.  Quantitative molecular virology in patient management.

Authors:  W Preiser; B Elzinger; N S Brink
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  HCV infection should be managed in specialist centres.

Authors:  J L Brown
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

3.  Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Authors:  G Gerken; T Rothaar; M G Rumi; R Soffredini; M Trippler; M J Blunk; A Butcher; S Soviero; G Colucci
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Exposure to blood borne viruses and the hepatitis B vaccination status among healthcare workers in inner London.

Authors:  P Gyawali; P S Rice; A J Tilzey
Journal:  Occup Environ Med       Date:  1998-08       Impact factor: 4.402

5.  Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping.

Authors:  L M Webber; S Els; M B Taylor; W O Grabow
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

6.  Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory.

Authors:  J Albadalejo; R Alonso; R Antinozzi; M Bogard; A M Bourgault; G Colucci; T Fenner; H Petersen; E Sala; J Vincelette; C Young
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.